European Leukemia Trial Registry
Trial: CABL001X2101

More Details
Title Phase I Study of oral ABL001 in patients with CML or Ph+ALL
Scientific Title A phase I, multicenter, open-label study of oral ABL001 in patients with chronic myelogenous leukemia or Philadelphia Chromosome-positive acute lymphoblastic leukemia
Short Title CABL001X2101
Trialgroup CML-Studiengruppe
Type of Trial multicentric, single-group, prospective, open-label
Disease Chronic myeloid leukemia(CML) Accelerated phase
Acute lymphoblastic leukemia(ALL) Ph/BCR ABL +
Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status Active
Start of Recruitment 15.04.2014
Leader Serve, Prof. Dr. med., Hubert
Contactperson

Administrative needs
Binckebanck, Anja
Tel: +49 (0)69 6301-6221
Fax: +49 (0)69 6301-7463
Email: binckebanck@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 28.08.2014 Johannes Kraus
changed 28.11.2019 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org